Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

926
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
926
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

677
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
677
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.2K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.2K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.3K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

3.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

613
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
613

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electric Security Fences for Power Substations: Electrical Safety of Induced Potentials.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Civilian "Stun" Guns: Neural or Aural Stimulation?

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Electrical Safety and Performance of E-Band devices Relative to Relevant Requirements of International Electrical Standards.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

One size fits all: Enhanced zero-shot text classification for patient listening on social media.

Frontiers in artificial intelligence·2025
Same author

A Mixed Methods Assessment of an Online Mental Health and Resilience Program for Agricultural Sector Students.

Journal of agromedicine·2024
Same author

Are adverse events higher among patients with acute optic neuritis prescribed glucocorticoids? A retrospective, longitudinal cohort study.

BMJ open·2024

Related Experiment Video

Updated: Mar 27, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

16.5K

Transthoracic ventricular fibrillation charge thresholds.

Dorin Panescu, Mark Kroll, Chris Andrews

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |January 7, 2016
    PubMed
    Summary

    This study introduces a unified transthoracic charge ventricular fibrillation threshold (VFT) model for stimuli durations from 1 μs to 300 s. The model reveals three distinct behavioral regions, improving understanding of cardiac stimulation effects.

    More Related Videos

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
    05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    8.6K
    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
    16:40

    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

    Published on: February 28, 2012

    27.0K

    Related Experiment Videos

    Last Updated: Mar 27, 2026

    A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
    09:47

    A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

    Published on: April 26, 2015

    16.5K
    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
    05:36

    Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

    Published on: January 30, 2020

    8.6K
    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
    16:40

    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

    Published on: February 28, 2012

    27.0K

    Area of Science:

    • Biomedical Engineering
    • Cardiovascular Research
    • Electrical Safety

    Background:

    • Current standards (IEC 60479-1, -2) use current-based ventricular fibrillation thresholds (VFTs) for limited stimulus durations.
    • Electrical charge, not RMS current, is more representative of cardiac stimulation effects.
    • Existing models lack a unified approach for transthoracic charge VFTs across a wide range of stimulus durations.

    Purpose of the Study:

    • To develop a novel, unified transthoracic charge VFT model.
    • To cover stimulus durations from 1 μs to 300 s.
    • To analyze charge VFT behavior across diverse stimulus durations.

    Main Methods:

    • Compiled VFT data from prior animal studies and published reports, including data underlying IEC standards.
    • Developed a unified charge model applicable to a broad range of stimulus durations (1 μs - 300 s).
    • Analyzed data to identify distinct behavioral regions of charge VFT versus stimulus duration.

    Main Results:

    • Established a consistent dataset for charge VFTs across 1 μs - 300 s stimulus durations.
    • Predicted a transthoracic charge VFT of 1 mC at 1 μs and 10 C at 300 s.
    • Identified three distinct behavioral regions for charge VFT across the stimulus duration spectrum.

    Conclusions:

    • Presents the first unified charge-based transthoracic VFT model for stimulus durations from 1 μs to 300 s.
    • The model demonstrates three distinct behavioral regions: Weiss charge strength-duration, constant charge, and constant current approximations.
    • This model enhances the understanding of electrical injury thresholds and cardiac stimulation effects over extended durations.